Cabozantinib for untreated advanced renal cell carcinoma

Equality Impact Assessment (Guidance development) (PDF 230 KB)

Final appraisal determination

Final appraisal determination document (PDF 371 KB)

Committee papers (PDF 2.2 MB)

Public committee slides (PDF 467 KB)

Draft guidance

Appraisal consultation document (PDF 385 KB)

Committee papers (PDF 19.33 MB)

Public committee slides (PDF 871 KB)

Final scope (PDF 84 KB)

Final matrix (PDF 260 KB)

NICE's response to comments on the draft scope and provisional matrix (PDF 117 KB)

Equality impact assessment (Scoping) (PDF 172 KB)

Draft scope post referral (PDF 241 KB)

Draft matrix post referral (PDF 261 KB)